529
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumonia

ORCID Icon, &
Pages 265-271 | Received 08 Sep 2020, Accepted 19 Oct 2020, Published online: 02 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Thomas P. Lodise, Matteo Bassetti, Ricard Ferrer, Thierry Naas, Yoshihito Niki, David L. Paterson, Markus Zeitlinger & Roger Echols. (2022) All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies. Expert Review of Anti-infective Therapy 20:5, pages 707-719.
Read now
Joseph P. Lynch$suffix/text()$suffix/text(), Nina M. Clark & George G. Zhanel. (2021) Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases. Expert Opinion on Pharmacotherapy 22:11, pages 1455-1474.
Read now

Articles from other publishers (2)

Rongxin Liang, Dongxing Wang, Mingjin Hu, Yuxia Gu, Meijun Wang, Dan Hu, Mingan Zhu & Meng Wang. (2023) In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii. The Journal of Antibiotics.
Crossref
Shio-Shin Jean, Dorji Harnod & Po-Ren Hsueh. (2022) Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers in Cellular and Infection Microbiology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.